|
1
|
Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC.
|
Lancet Oncol
|
2012
|
3.26
|
|
2
|
Which domains should be included in a cancer pain classification system? Analyses of longitudinal data.
|
Pain
|
2012
|
2.07
|
|
3
|
The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients.
|
Pain
|
2005
|
2.00
|
|
4
|
A cross-sectional study on prevalence of pain and breakthrough pain among an unselected group of outpatients in a tertiary cancer clinic.
|
Support Care Cancer
|
2014
|
1.97
|
|
5
|
|
Tidsskr Nor Laegeforen
|
2016
|
1.94
|
|
6
|
Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene.
|
Pain
|
2006
|
1.72
|
|
7
|
Prevalence and predictors of cognitive dysfunction in opioid-treated patients with cancer: a multinational study.
|
J Clin Oncol
|
2011
|
1.61
|
|
8
|
Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S--Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double-blinded, randomised clinical trial.
|
Trials
|
2011
|
1.51
|
|
9
|
Genetic variation in the catechol-O-methyltransferase (COMT) gene and morphine requirements in cancer patients with pain.
|
Mol Pain
|
2008
|
1.41
|
|
10
|
Further restrictions for ICU research.
|
Intensive Care Med
|
2005
|
1.40
|
|
11
|
[71-year old man with severe circulatory collapse following heart arrest].
|
Tidsskr Nor Laegeforen
|
2010
|
1.39
|
|
12
|
Health care providers underestimate symptom intensities of cancer patients: a multicenter European study.
|
Health Qual Life Outcomes
|
2010
|
1.34
|
|
13
|
Antiplatelet effect of clopidogrel is reduced in patients treated with therapeutic hypothermia after cardiac arrest.
|
Resuscitation
|
2010
|
1.29
|
|
14
|
Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7 H268Y and UGT1A1*28 polymorphisms in cancer patients on chronic morphine therapy.
|
Eur J Clin Pharmacol
|
2002
|
1.04
|
|
15
|
Opioid switching from morphine to methadone causes a minor but not clinically significant increase in QTc time: A prospective 9-month follow-up study.
|
J Pain Symptom Manage
|
2006
|
1.03
|
|
16
|
The establishment of the GENEQOL consortium to investigate the genetic disposition of patient-reported quality-of-life outcomes.
|
Twin Res Hum Genet
|
2009
|
1.03
|
|
17
|
Validation of the brief pain inventory in patients six months after cardiac surgery.
|
J Pain Symptom Manage
|
2007
|
1.02
|
|
18
|
Clinical and genetic factors associated with nausea and vomiting in cancer patients receiving opioids.
|
Eur J Cancer
|
2011
|
1.01
|
|
19
|
The systemic inflammatory response and its relationship to pain and other symptoms in advanced cancer.
|
Oncologist
|
2013
|
0.99
|
|
20
|
Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study.
|
Eur J Clin Pharmacol
|
2011
|
0.96
|
|
21
|
Which variables are associated with pain intensity and treatment response in advanced cancer patients?--Implications for a future classification system for cancer pain.
|
Eur J Pain
|
2010
|
0.94
|
|
22
|
The Edmonton Classification System for Cancer Pain: comparison of pain classification features and pain intensity across diverse palliative care settings in eight countries.
|
J Palliat Med
|
2013
|
0.92
|
|
23
|
Which mini-mental state exam items can be used to screen for delirium and cognitive impairment?
|
J Pain Symptom Manage
|
2005
|
0.91
|
|
24
|
Intensity and treatment of symptoms in 3,030 palliative care patients: a cross-sectional survey of the EAPC Research Network.
|
J Opioid Manag
|
2009
|
0.91
|
|
25
|
Influences on the pharmacokinetics of oxycodone: a multicentre cross-sectional study in 439 adult cancer patients.
|
Eur J Clin Pharmacol
|
2010
|
0.90
|
|
26
|
A GTP cyclohydrolase 1 genetic variant delays cancer pain.
|
Pain
|
2009
|
0.90
|
|
27
|
The Brief Pain Inventory: pain's interference with functions is different in cancer pain compared with noncancer chronic pain.
|
Clin J Pain
|
2008
|
0.88
|
|
28
|
Biological pathways and genetic variables involved in pain.
|
Qual Life Res
|
2010
|
0.87
|
|
29
|
Biological pathways, candidate genes, and molecular markers associated with quality-of-life domains: an update.
|
Qual Life Res
|
2014
|
0.86
|
|
30
|
Multiple Loci modulate opioid therapy response for cancer pain.
|
Clin Cancer Res
|
2011
|
0.86
|
|
31
|
Intranasal midazolam: a comparison of two delivery devices in human volunteers.
|
J Pharm Pharmacol
|
2006
|
0.86
|
|
32
|
Inadequate symptom control in advanced cancer patients across Europe.
|
Support Care Cancer
|
2010
|
0.85
|
|
33
|
Opioid switching from oral slow release morphine to oral methadone may improve pain control in chronic non-malignant pain: a nine-month follow-up study.
|
Palliat Med
|
2006
|
0.85
|
|
34
|
The dimensionality of pain: palliative care and chronic pain patients differ in their reports of pain intensity and pain interference.
|
Pain
|
2011
|
0.84
|
|
35
|
Early pharmacokinetics of nasal fentanyl: is there a significant arterio-venous difference?
|
Eur J Clin Pharmacol
|
2008
|
0.84
|
|
36
|
Expert conference on cancer pain assessment and classification--the need for international consensus: working proposals on international standards.
|
BMJ Support Palliat Care
|
2011
|
0.83
|
|
37
|
Cancer patients' barriers to pain management and psychometric properties of the Norwegian version of the Barriers Questionnaire II.
|
Scand J Caring Sci
|
2008
|
0.83
|
|
38
|
Genetic, pathological and physiological determinants of transdermal fentanyl pharmacokinetics in 620 cancer patients of the EPOS study.
|
Pharmacogenet Genomics
|
2014
|
0.83
|
|
39
|
Effects of hypothermia on the disposition of morphine, midazolam, fentanyl, and propofol in intensive care unit patients.
|
Drug Metab Dispos
|
2012
|
0.82
|
|
40
|
Health-related quality of life three years after coronary surgery: a comparison with the general population.
|
Scand Cardiovasc J
|
2006
|
0.82
|
|
41
|
The European Union--not united in opioid use.
|
Palliat Med
|
2005
|
0.81
|
|
42
|
Survival and quality of life in an elderly cardiac surgery population: 5-year follow-up.
|
Eur J Cardiothorac Surg
|
2013
|
0.80
|
|
43
|
Patterns of smoking behaviour in patients following cardiac surgery. A prospective study.
|
Scand Cardiovasc J
|
2010
|
0.80
|
|
44
|
Long-term survival and quality of life after intensive care for patients 80 years of age or older.
|
Ann Intensive Care
|
2015
|
0.80
|
|
45
|
Long-Term Outcomes After ICU Admission Triage in Octogenarians.
|
Crit Care Med
|
2017
|
0.79
|
|
46
|
Risk factors and early pharmacological interventions to prevent chronic postsurgical pain following cardiac surgery.
|
Am J Cardiovasc Drugs
|
2014
|
0.79
|
|
47
|
Is there a genetic cause of appetite loss?-an explorative study in 1,853 cancer patients.
|
J Cachexia Sarcopenia Muscle
|
2012
|
0.79
|
|
48
|
Undertreatment of pain in the prehospital setting: a comparison between trauma patients and patients with chest pain.
|
Eur J Emerg Med
|
2013
|
0.79
|
|
49
|
Direct transport versus interhospital transfer of patients with severe head injury in Norway.
|
Eur J Emerg Med
|
2008
|
0.79
|
|
50
|
Recovery patterns and health-related quality of life in older patients undergoing cardiac surgery: a prospective study.
|
Eur J Cardiovasc Nurs
|
2012
|
0.78
|
|
51
|
Is oxycodone efficacy reflected in serum concentrations? A multicenter, cross-sectional study in 456 adult cancer patients.
|
J Pain Symptom Manage
|
2012
|
0.78
|
|
52
|
[Application of pupillometry and pupillary reactions in medical research].
|
Tidsskr Nor Laegeforen
|
2005
|
0.77
|
|
53
|
Propofol and remifentanil versus midazolam and fentanyl for sedation during therapeutic hypothermia after cardiac arrest: a randomised trial.
|
Intensive Care Med
|
2012
|
0.77
|
|
54
|
Management of opioid-induced nausea and vomiting in cancer patients: systematic review and evidence-based recommendations.
|
Palliat Med
|
2011
|
0.77
|
|
55
|
Lack of association between genetic variability and multiple pain-related outcomes in a large cohort of patients with advanced cancer: the European Pharmacogenetic Opioid Study (EPOS).
|
BMJ Support Palliat Care
|
2012
|
0.76
|
|
56
|
Opioids in pain management of mesothelioma and lung cancer patients.
|
Acta Oncol
|
2012
|
0.76
|
|
57
|
Long term methadone for chronic pain: a pilot study of pharmacokinetic aspects.
|
Eur J Pain
|
2006
|
0.76
|
|
58
|
Can cancer patients assess the influence of pain on functions? A randomised, controlled study of the pain interference items in the Brief Pain Inventory.
|
BMC Palliat Care
|
2007
|
0.76
|
|
59
|
Interviews with patients with advanced cancer--another step towards an international cancer pain classification system.
|
Support Care Cancer
|
2012
|
0.76
|
|
60
|
[Therapeutic hypothermia--pharmacology and pathophysiology].
|
Tidsskr Nor Laegeforen
|
2007
|
0.76
|
|
61
|
Predication of cancer patients' survival by pain interference items is not the same as evidence that pain intensity is a survival predictor.
|
J Clin Oncol
|
2008
|
0.75
|
|
62
|
Confusion with cerebral perfusion pressure in a literature review of current guidelines and survey of clinical practice.
|
Scand J Trauma Resusc Emerg Med
|
2013
|
0.75
|
|
63
|
[Biobank legislation stops research using critically ill patients].
|
Tidsskr Nor Laegeforen
|
2005
|
0.75
|
|
64
|
The role of sex in health-related quality of life after cardiac surgery: a prospective study.
|
Eur J Cardiovasc Prev Rehabil
|
2008
|
0.75
|
|
65
|
|
Tidsskr Nor Laegeforen
|
2017
|
0.75
|
|
66
|
[Opioid switching and methadone in pain relief].
|
Tidsskr Nor Laegeforen
|
2006
|
0.75
|
|
67
|
[Symptoms assessment in cancer patients on admission to a hospital].
|
Tidsskr Nor Laegeforen
|
2005
|
0.75
|
|
68
|
Common sense won: engagement from experts repealed Norwegian restrictions for ICU research.
|
Intensive Care Med
|
2007
|
0.75
|
|
69
|
Variability in UDP-glucuronosyltransferase genes and morphine metabolism: observations from a cross-sectional multicenter study in advanced cancer patients with pain.
|
Pharmacogenet Genomics
|
2013
|
0.75
|
|
70
|
[Use of opioids against severe cancer pain].
|
Tidsskr Nor Laegeforen
|
2004
|
0.75
|
|
71
|
A double-blind, randomized, crossover comparison between single-dose and double-dose immediate-release oral morphine at bedtime in cancer patients.
|
J Pain Symptom Manage
|
2008
|
0.75
|
|
72
|
[Intensive care of patients with acute liver failure].
|
Tidsskr Nor Laegeforen
|
2010
|
0.75
|
|
73
|
[Cancer patients should not feel pain].
|
Tidsskr Nor Laegeforen
|
2005
|
0.75
|
|
74
|
Clopidogrel does not work following cardiopulmonary resuscitation.
|
Eur J Clin Pharmacol
|
2013
|
0.75
|
|
75
|
Health-related quality of life in long term-survivors of thoracoabdominal aortic aneurysm repair.
|
J Vasc Nurs
|
2005
|
0.75
|
|
76
|
[Intensive medicine and its challenges].
|
Tidsskr Nor Laegeforen
|
2010
|
0.75
|